Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-05-17

Clinical Trial Update: Midodrine for Ischemic Stroke With Penumbra

View source ↗

Summary

A clinical trial evaluating midodrine for ischemic stroke with penumbra has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midodrine (Midodrine)

Snippet

Sponsor: University of Utah | Conditions: Stroke | Status: WITHDRAWN